MX2020007237A - Terapia combinada y profilaxis de infecciones del aparato genital. - Google Patents

Terapia combinada y profilaxis de infecciones del aparato genital.

Info

Publication number
MX2020007237A
MX2020007237A MX2020007237A MX2020007237A MX2020007237A MX 2020007237 A MX2020007237 A MX 2020007237A MX 2020007237 A MX2020007237 A MX 2020007237A MX 2020007237 A MX2020007237 A MX 2020007237A MX 2020007237 A MX2020007237 A MX 2020007237A
Authority
MX
Mexico
Prior art keywords
genital tract
tract infections
prophylaxis
combined therapy
gonorrhoeae
Prior art date
Application number
MX2020007237A
Other languages
English (en)
Spanish (es)
Inventor
Michael W Russell
Yingru Liu
Nejat K Egilmez
Original Assignee
The Research Foundation Of The State Univ Of New York
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US15/824,700 external-priority patent/US20180071379A1/en
Priority claimed from US16/138,526 external-priority patent/US20190008941A1/en
Application filed by The Research Foundation Of The State Univ Of New York filed Critical The Research Foundation Of The State Univ Of New York
Publication of MX2020007237A publication Critical patent/MX2020007237A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/208—IL-12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/095—Neisseria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55522—Cytokines; Lymphokines; Interferons
    • A61K2039/55527—Interleukins
    • A61K2039/55538—IL-12

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Otolaryngology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
MX2020007237A 2017-11-28 2018-11-27 Terapia combinada y profilaxis de infecciones del aparato genital. MX2020007237A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15/824,700 US20180071379A1 (en) 2012-05-29 2017-11-28 Combined therapy and prophylaxis for genital tract infections
US16/138,526 US20190008941A1 (en) 2012-05-29 2018-09-21 Combined therapy and prophylaxis for genital tract infections
PCT/US2018/062590 WO2019108528A1 (fr) 2017-11-28 2018-11-27 Polythérapie et prophylaxie contre des infections du tractus génital

Publications (1)

Publication Number Publication Date
MX2020007237A true MX2020007237A (es) 2020-09-25

Family

ID=66665780

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2020007237A MX2020007237A (es) 2017-11-28 2018-11-27 Terapia combinada y profilaxis de infecciones del aparato genital.

Country Status (7)

Country Link
EP (1) EP3716995A4 (fr)
JP (1) JP2021504478A (fr)
CN (1) CN111698998A (fr)
AU (1) AU2018375133A1 (fr)
CA (1) CA3083741A1 (fr)
MX (1) MX2020007237A (fr)
WO (1) WO2019108528A1 (fr)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2289545T (pt) * 2000-01-17 2016-09-06 Glaxosmithkline Biologicals Sa Vacina de omv suplementada contra meningococos
US7892567B2 (en) * 2007-10-01 2011-02-22 Board Of Regents, The University Of Texas System Methods and compositions for immunization against chlamydial infection and disease
US9827319B2 (en) * 2012-05-29 2017-11-28 The Research Foundation For The State University Of New York Combined therapy and prophylaxis for genital tract infections

Also Published As

Publication number Publication date
CN111698998A (zh) 2020-09-22
CA3083741A1 (fr) 2019-06-19
EP3716995A1 (fr) 2020-10-07
AU2018375133A1 (en) 2020-06-18
EP3716995A4 (fr) 2021-08-25
WO2019108528A1 (fr) 2019-06-06
JP2021504478A (ja) 2021-02-15

Similar Documents

Publication Publication Date Title
AU2018256591A1 (en) Thieno[3,2-d]pyrimidines derivatives for the treatment of viral infections
MX2016011132A (es) Métodos para tratar una infección cutánea mediante la administración de un antagonista de il-4r.
NZ728072A (en) Modulators of toll-like receptors for the treatment of hiv
MX2021015427A (es) Vesiculas extracelulares microbianas procesadas.
MX2020000467A (es) Compuestos retinoides y rexinoides inmunomoduladores en combinacion con inmunomoduladores para inmunoterapia contra cancer.
MX2016008397A (es) Composicion para usarse en el tratamiento de tos persistente.
PH12019502316A1 (en) Combination cancer immunotheraphy with pentaaza macrocyclic ring complex
MX2019012757A (es) Composicion farmaceutica para administracion oral que comprende enzalutamida.
MX2020011295A (es) Tratamiento de dermatitis atopica.
MX2019004973A (es) Moduladores de ror gamma.
MX2021007453A (es) Administracion perineural de resiniferatoxina para el tratamiento del dolor maladaptativo.
MX2023000187A (es) Dosificacion de vibegron para el tratamiento de vejiga sobreactiva.
MX2020000009A (es) Nuevas formulaciones en capsulas de gelatina blandas de secnidazol y sus usos.
MX2020007237A (es) Terapia combinada y profilaxis de infecciones del aparato genital.
EA201992431A1 (ru) Комбинированная иммунотерапия рака с использованием пента-аза-макроциклического кольцевого комплекса
MX2018015208A (es) Andrografolido para tratar formas progresivas de esclerosis multiple.
MX2019004591A (es) Metodo para preparar una formulacion inmunosupresora.
MX2023002339A (es) Vacunas contra infecciones por sars-cov-2.
WO2019075168A3 (fr) Procédés de réduction des effets secondaires d'une thérapie par conjugués de médicament anticorps anti-cd30
UA116659C2 (uk) Застосування адсорбованого гомогенату трутневого розплоду й вітамінів групи d і/або їх активних метаболітів для профілактики та лікування гострих респіраторних захворювань і грипу
WO2018062876A3 (fr) Kit pour le traitement de l'arthrose visant à réduire la douleur
MX2018015240A (es) Composiciones que comprenden timolol y su uso en el tratamiento de rosacea mediante administracion topica.
WO2019035143A3 (fr) Miel médicamenteux et son procédé de préparation
CO2018001531A2 (es) Lisobactina para su uso en el tratamiento de la mastitis bovina
RU2009123045A (ru) Способ снижения негативного влияния шума на антиоксидантную систему организма человека